BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22661763)

  • 21. Evaluation of Evidence of Statistical Support and Corroboration of Subgroup Claims in Randomized Clinical Trials.
    Wallach JD; Sullivan PG; Trepanowski JF; Sainani KL; Steyerberg EW; Ioannidis JP
    JAMA Intern Med; 2017 Apr; 177(4):554-560. PubMed ID: 28192563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study.
    Liu P; Ioannidis JPA; Ross JS; Dhruva SS; Luxkaranayagam AT; Vasiliou V; Wallach JD
    BMC Med; 2019 Oct; 17(1):188. PubMed ID: 31639007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rudiments of subgroup analyses.
    Moyé LA
    Prog Cardiovasc Dis; 2012; 54(4):338-42. PubMed ID: 22226001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trials and meta-analysis in medical education: what role do they play?
    Cook DA
    Med Teach; 2012; 34(6):468-73. PubMed ID: 22489980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized controlled trial quality in pediatric physical therapy.
    Paci M; Landi N; Marchettini M; Baccini M
    Phys Occup Ther Pediatr; 2014 Aug; 34(3):260-70. PubMed ID: 23988236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analyses frequently pooled different study types together: a meta-epidemiological study.
    Bun RS; Scheer J; Guillo S; Tubach F; Dechartres A
    J Clin Epidemiol; 2020 Feb; 118():18-28. PubMed ID: 31698062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subgroup analysis in randomized controlled trials appeared to be dependent on whether relative or absolute effect measures were used.
    Venekamp RP; Rovers MM; Hoes AW; Knol MJ
    J Clin Epidemiol; 2014 Apr; 67(4):410-5. PubMed ID: 24508145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Issues in subgroup analyses and meta-analyses of clinical trials.
    Bigger JT
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S6-8. PubMed ID: 12950510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic reviews of randomized controlled trials: the need for complete data.
    Clarke MJ; Stewart LA
    J Eval Clin Pract; 1995 Nov; 1(2):119-26. PubMed ID: 9238566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardization for subgroup analysis in randomized controlled trials.
    Varadhan R; Wang SJ
    J Biopharm Stat; 2014; 24(1):154-67. PubMed ID: 24392983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of analytical methods used to study subgroups in (individual patient data) meta-analyses.
    Koopman L; van der Heijden GJ; Glasziou PP; Grobbee DE; Rovers MM
    J Clin Epidemiol; 2007 Oct; 60(10):1002-9. PubMed ID: 17884593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cumulative subgroup analysis to reduce waste in clinical research for individualised medicine.
    Song F; Bachmann MO
    BMC Med; 2016 Dec; 14(1):197. PubMed ID: 27974045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approaches to data analyses of clinical trials.
    Furberg CD; Friedman LM
    Prog Cardiovasc Dis; 2012; 54(4):330-4. PubMed ID: 22225999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How often can meta-analyses of individual-level data individualize treatment? A meta-epidemiologic study.
    Schuit E; Li AH; Ioannidis JPA
    Int J Epidemiol; 2019 Apr; 48(2):596-608. PubMed ID: 30445577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence from randomized controlled trials, meta-analyses, and subgroup analyses.
    Sacristán JA
    JAMA; 2010 Apr; 303(13):1253-4; author reply 1254-5. PubMed ID: 20371780
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of ethnic minorities and gender effects in clinical trials: opportunities lost and rediscovered.
    Moyé LA; Powell JH
    J Natl Med Assoc; 2001 Dec; 93(12 Suppl):29S-34S. PubMed ID: 11798062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information.
    Williamson SF; Grayling MJ; Mander AP; Noor NM; Savage JS; Yap C; Wason JMS
    J Clin Epidemiol; 2022 Oct; 150():72-79. PubMed ID: 35788399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses.
    Gluud LL; Thorlund K; Gluud C; Woods L; Harris R; Sterne JA
    Ann Intern Med; 2008 Aug; 149(3):219. PubMed ID: 18942172
    [No Abstract]   [Full Text] [Related]  

  • 39. An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials.
    Emerson JD; Burdick E; Hoaglin DC; Mosteller F; Chalmers TC
    Control Clin Trials; 1990 Oct; 11(5):339-52. PubMed ID: 1963128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 21st Century Evidence: Randomized Controlled Trials Versus Systematic Reviews and Meta-Analyses.
    Agarwal A; Rochwerg B; Sevransky JE
    Crit Care Med; 2021 Dec; 49(12):2001-2002. PubMed ID: 34582418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.